Cargando…
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...
Autores principales: | Li, Xu, Yu, Jinchao, Zhang, Zhiming, Ren, Jing, Peluffo, Alex E., Zhang, Wen, Zhao, Yujie, Wu, Jiawei, Yan, Kaijing, Cohen, Daniel, Wang, Wenjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008783/ https://www.ncbi.nlm.nih.gov/pubmed/33817623 http://dx.doi.org/10.1016/j.medidd.2021.100090 |
Ejemplares similares
-
Insights into bioinformatic approaches for repurposing compounds as
anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021) -
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
por: Venkatraman, Simran, et al.
Publicado: (2022) -
Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
por: Zheng, Pan, et al.
Publicado: (2022) -
Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for COVID‐19
por: Li, Jiapeng, et al.
Publicado: (2022) -
Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)